RSS   Newsletter   Contact   Advertise with us
Post Online Media

Agenus appoints Jean-Marie Cuillerot chief medical officer

Jean Marie CuillerotAgenus Inc., an immuno-oncology company, announced that Jean-Marie Cuillerot was appointed chief medical officer.
Article continues below

READ MORE Agenus appoints VP and global head of clinical development

Dr. Cuillerot initially joined Agenus in 2016 as the Vice President and Global Head of Clinical Development. Dr. Cuillerot joined Agenus as an expert clinician in immuno-oncology drug development.

His past affiliations with Merck Serono and Bristol-Myers Squibb were accompanied by significant accomplishments that included the advancement of the PD-L1 antagonist antibody avelumab from first in man to regulatory filing in three and a half years.

In addition, Dr. Cuillerot was a key contributor in the development and filing of Yervoy

Dr. Cuillerot received his B.S. in biochemistry, M.D., and M.Sc. in cellular and molecular biology at the University Louis Pasteur. He is board certified in hematology and immunology.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy